Home / Share Price Target / Aartipharm
Aarti Pharmalabs Share Price Target 2024, 2025, 2026 to 2039 With Charts
Aarti Pharmalabs Limited | |||
 | Symbol: AARTIPHARM | ||
| Price: ₹636.45 | |||
| Exchange: NSE | |||
| Healthcare -> Drug Manufacturers—Specialty & Generic | |||
Show Table of Contents
Table of Contents
- 1: Aarti Pharmalabs Brief Company Overview
- 1.1: Aarti Pharmalabs: A Global Leader in Pharmaceuticals
- 1.2: Aarti Pharmalabs Financial Performance
- 1.2.1: Is Aarti Pharmalabs A Good Buy For Long Term?
- 2: Approach 1: Technical Analysis Paired With Price Action
- 2.1: Aarti Pharmalabs Share Price Target For 2024
- 2.1.1: Aarti Pharmalabs Share Price Target Table For 2024
- 2.1.2: Summary: Aarti Pharmalabs Share Price Prediction For 2024
- 2.2: Aarti Pharmalabs Share Price Target For 2025
- 2.2.1: Aarti Pharmalabs Share Price Target Table For 2025
- 2.2.2: Summary: Aarti Pharmalabs Share Price Prediction For 2025
- 3: Approach 2: Machine Learning By Studying Historical Prices
- 3.1: Aarti Pharmalabs Long Term Share Price Prediction Chart From 2024, 2025, 2026 to 2039
- 3.2: Aarti Pharmalabs Share Price Target Table From 2024, 2025, 2026 to 2039
- 4: Aarti Pharmalabs Past Performance
Aarti Pharmalabs Brief Company Overview
Aarti Pharmalabs: A Global Leader in Pharmaceuticals
Aarti Pharmalabs Limited is a leading manufacturer and supplier of active pharmaceutical ingredients (APIs) and pharmaceutical intermediates. The company's products are used in various therapeutic areas, including anti-hypertensive, anti-asthmatic, anti-cancer, central nervous system (CNS) agents, skincare, decongestant, cardiovascular, anti-thalassemic, analgesic, anti-diabetic, and ophthalmologic medications.
Aarti Pharmalabs also develops new chemical entities (NCEs), regulatory starting materials (RSM), basic starting materials, key starting materials (KSM), key building blocks, xanthine derivatives, and allied products. The company provides contract development and manufacturing services for drug substance projects comprising NCEs, APIs, RSMs, and Intermediates for innovator pharmaceutical and biotech companies internationally.
Established in 2019, Aarti Pharmalabs has a strong reputation in the industry for its commitment to quality and customer satisfaction. The company has a diverse product range and a global presence, serving customers in India and internationally.
Advertisement
Aarti Pharmalabs Financial Performance
| Metric | Value | Description |
|---|---|---|
| Market Capital | 5,739.79 Crore | Market valuation of Aarti Pharmalabs's shares. |
| Revenue (TTM) | 1,852.59 Crore | Total revenue generated by Aarti Pharmalabs over the past twelve months. |
| Net Income (TTM) | +216.89 Crore | Net Profit or Loss after all the expenses over the past twelve months. |
| Operating Margin | 19.45% | Income from operations as a percentage of revenue, before taxes and interest. |
| Profit Margin | 11.7% | Net income as a percentage of revenue, after all expenses. |
| Revenue Growth (Quarterly) | +4.3% | Change in revenue compared to the previous quarter. |
| Earnings Growth (YOY Quarterly) | +52.2% | Change in earnings compared to the same quarter last year. |
| Debt-to-Equity (D/E) Ratio | 16.23 | Company's total debt divided by total shareholder equity. |
| Total Debt | 285.24 Crore | Sum of Aarti Pharmalabs's current & long-term financial obligations. |
| Total Cash | 94.44 Crore | Total amount of liquid funds available to Aarti Pharmalabs. |
Is Aarti Pharmalabs A Good Buy For Long Term?
Aarti Pharmalabs shows promising signs for long-term investment. The company has a solid revenue stream, with a 4.3% increase in revenue compared to the previous quarter, and a healthy profit margin of 11.7%. While the debt of 285.24 Crore may be a concern, the 25.12% return over the past three months and 75.19% return over the past year suggest strong investor confidence. However, the company's lackluster performance over the past three and five years (0% returns) necessitates further investigation into the underlying factors.
To predict the Aarti Pharmalabs's future market prices, we harnessed 2 dynamic approaches:
Approach 1: Technical Analysis Paired With Price Action
Approach 2: Machine Learning By Studying Historical Prices
Approach 1: Technical Analysis Paired With Price Action
Aarti Pharmalabs Share Price Target For 2024
The line chart displays the monthly closing prices of Aarti Pharmalabs with a black line. The green line shows three potential target prices for 2024, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Aarti Pharmalabs shares in 2024, see the table below.
Advertisement
Aarti Pharmalabs Share Price Target Table For 2024
| Aarti Pharmalabs's Levels | Value | Reason/Importance |
|---|---|---|
| 2024 Target 3 | 712.57 (+11.96%) | Price Action: Chart |
| 2024 Target 2 | 699.28 (+9.87%) | Price Action: Chart |
| 2024 Target 1 | 692.36 (+8.78%) | Fibonacci Extension Level 123.6% |
| Current Price | 636.45 | Aarti Pharmalabs's 1 share price as of Mon 01 Jul 2024 |
| Stop Loss 1 | 619.04 (-2.74%) | Price Action: 19 Jun 2024 Low |
| Stop Loss 2 | 611.79 (-3.88%) | Price Action: 14 Jun 2024 High |
| Stop Loss 3 | 605.00 (-4.95%) | Price Action: Jun 2024 Low |
Summary: Aarti Pharmalabs Share Price Prediction For 2024
In summary, Aarti Pharmalabs has surged by ₹132.00, achieving a notable +26.17% increase from 1st January 2024 to 01 Jul 2024. Our analysis of Aarti Pharmalabs for 2024 predicts an additional rise of 8.78% to 11.96% by the end of 2024 with three potential targets T1: 692.36, T2: 699.28, T3: 712.57. Stop Loss at SL1: 619.04, SL2: 611.79, SL3: 605.00.
Aarti Pharmalabs has a 52-week high of ₹653.00, acting as a crucial resistance level - a ceiling that could challenge further price increase. Conversely, it has a 52-week low of ₹320.29, a critical support level - think of this as a safety net where the price might stop falling.
After looking at 2024's share price prediction, let's now check what 2025 might hold for Aarti Pharmalabs.
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Aarti Pharmalabs Share Price Target For 2025
The line chart displays the monthly closing prices of Aarti Pharmalabs with a black line. The green line shows three potential target prices for 2025, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Aarti Pharmalabs shares in 2025, see the table below.
Advertisement
Aarti Pharmalabs Share Price Target Table For 2025
| Aarti Pharmalabs's Levels | Value | Reason/Importance |
|---|---|---|
| 2025 Target 3 | 900.28 (+41.45%) | Fibonacci Extension Level 171.8% |
| 2025 Target 2 | 883.68 (+38.84%) | Price Action: Chart |
| 2025 Target 1 | 874.93 (+37.47%) | Custom Fibonacci Extension Lvl 64.9% |
| Current Price | 636.45 | Aarti Pharmalabs's 1 share price as of Mon 01 Jul 2024 |
| Stop Loss 1 | 580.65 (-8.77%) | Price Action: 07 Jun 2024 Low |
| Stop Loss 2 | 570.65 (-10.34%) | Technical Indicator: MA50 |
| Stop Loss 3 | 560.00 (-12.02%) | Price Action: Jan 2024 High |
Summary: Aarti Pharmalabs Share Price Prediction For 2025
In summary, Aarti Pharmalabs has surged by ₹132.00, achieving a notable +26.17% increase from 1st January 2024 to 01 Jul 2024. Our analysis of Aarti Pharmalabs for 2025 predicts an additional rise of 37.47% to 41.45% by the end of 2025 with three potential targets T1: 874.93, T2: 883.68, T3: 900.28. Stop Loss at SL1: 580.65, SL2: 570.65, SL3: 560.00.
Aarti Pharmalabs has a All-Time high of ₹653.00, acting as a crucial resistance level - a ceiling that could challenge further price increase. Conversely, it has a 52-week low of ₹320.29, a critical support level - think of this as a safety net where the price might stop falling.
After looking at 2024's and 2025's share price prediction, you might wonder what are short term targets for Aarti Pharmalabs, we have created a specific page for that check here: Aarti Pharmalabs Share Price Target For Tomorrow & Next Week
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Approach 2: Machine Learning By Studying Historical Prices
Aarti Pharmalabs Long Term Share Price Prediction Chart From 2024, 2025, 2026 to 2039
This chart presents a detailed projection of Aarti Pharmalabs share price predictions from 2024, 2025, 2026 to 2039. This share price Prediction represents a CAGR of 13.87% over the next 15 years.
For complete year by year Aarti Pharmalabs long term share price target from 2024, 2025 to 2039 check the below table.
Aarti Pharmalabs Share Price Target Table From 2024, 2025, 2026 to 2039
| Year | Aarti Pharmalabs Target | YoY Change % |
|---|---|---|
| 2024 | ₹636.45 | [Current Price] |
| 2024 | ₹710.08 | 11.56% |
| 2025 | ₹955.91 | 34.62% |
| 2026 | ₹1,234.23 | 29.11% |
| 2027 | ₹1,473.82 | 19.41% |
| 2028 | ₹1,737.76 | 17.9% |
| 2029 | ₹1,928.43 | 10.97% |
| 2030 | ₹2,177 | 12.88% |
| 2031 | ₹2,490.03 | 14.37% |
| 2032 | ₹2,719.83 | 9.22% |
| 2033 | ₹2,994.44 | 10.09% |
| 2034 | ₹3,146.77 | 5.08% |
| 2035 | ₹3,398.1 | 7.98% |
| 2036 | ₹3,745.83 | 10.23% |
| 2037 | ₹3,965.84 | 5.87% |
| 2038 | ₹4,251.12 | 7.19% |
| 2039 | ₹4,373.72 | 2.88% |
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Aarti Pharmalabs Past Performance
- In 2023, Aarti Pharmalabs opening price was ₹299.89
- As of Mon 01 Jul 2024 the price stands at ₹636.45.
- This represents a Compound Annual Growth Rate (CAGR) of 45.68%.
- In 1 year, an investment of 10,000 would have become ₹21,222.07.
As we wrap up, we hope you like our study on Aarti Pharmalabs share price predictions, please kindly note that these forecasts are based on technical analysis, past trends, and machine learning models. They are for educational purposes only, not investment advice.
Show Methodology We Use
Methodology Behind the Prediction
The share price predictions present on our site are derived from a robust model that incorporates multiple economic indicators, technical indicators, company performance metrics, and industry-specific factors.
We have historical share price data of all stocks for which we present targets, so we analyse historical trends from those past data and overlay them with projected market conditions to estimate future share prices of a stock.
- Aarti Pharmalabs Share Price History
- Aarti Pharmalabs Price Target Tomorrow
- Aarti Pharmalabs Dividend History
Disclaimer: Information is provided 'as is' and solely for informational and educational purposes, not for trading purposes or advice. We highly recommend to do your own research before making any investment.
